Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

306 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The safety of switching between therapeutic proteins.
Ebbers HC, Muenzberg M, Schellekens H. Ebbers HC, et al. Among authors: schellekens h. Expert Opin Biol Ther. 2012 Nov;12(11):1473-85. doi: 10.1517/14712598.2012.711308. Epub 2012 Jul 31. Expert Opin Biol Ther. 2012. PMID: 22849511 Review.
Safety and efficacy of biosimilars in oncology.
Schellekens H, Smolen JS, Dicato M, Rifkin RM. Schellekens H, et al. Lancet Oncol. 2016 Nov;17(11):e502-e509. doi: 10.1016/S1470-2045(16)30374-6. Lancet Oncol. 2016. PMID: 27819248 Review.
Structure-immunogenicity relationships of therapeutic proteins.
Hermeling S, Crommelin DJ, Schellekens H, Jiskoot W. Hermeling S, et al. Among authors: schellekens h. Pharm Res. 2004 Jun;21(6):897-903. doi: 10.1023/b:pham.0000029275.41323.a6. Pharm Res. 2004. PMID: 15212151 Review.
306 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page